Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

CAR-T Phenotype and Efficacy Is Impaired By Lymphoma-Associated CD39 + T Cells

Blood (2023) 142 (Supplement 1): 3500.

https://doi.org/10.1182/blood-2023-178113

Published: 2023

Journal Articles

Thrombosis Caused By a Novel Coagulation Factor IX Mutation (FIX Shanghai II)

Wenman WU, Rui Wang, Qin Xu, Guanzheng Wang, Shifeng Jiang, Can Lou, Xi Wu, Yanyan Shao, Yeling Lu, Yu Liu, Guanquan Xu, Qiulan Ding, Xiaobo Hu, Xuefeng Wang, Jing Dai

Blood (2023) 142 (Supplement 1): 1233.

https://doi.org/10.1182/blood-2023-184596

Published: 2023

Journal Articles

Sexual Health in Young Adult Patients after Chimeric Antigen Receptor T-Cell Therapy

Acadia Buro, Vivian Irizarry Gatell, Hayden J Fulton, Rebecca Blackwell, Kellie Zambrano, Yvelise Rodriguez, Xiaoyin Li, Xuefeng Wang, Laura B. Oswald, Rawan Faramand

Blood (2023) 142 (Supplement 1): 7378.

https://doi.org/10.1182/blood-2023-178242

Published: 2023

Journal Articles

Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup

Alyssa Obermayer, Sijie Yao, Jenny L. Smith, Rhonda E. Ries, Yi-Cheng Wang, Jason E Farrar, Scott N Furlan, Tim Triche, Xiaotu Ma, Benjamin J. Huang, Xuefeng Wang, Soheil Meshinchi, Timothy I. Shaw

Blood (2022) 140 (Supplement 1): 3385–3386.

https://doi.org/10.1182/blood-2022-163616

Published: 2022

Journal Articles

Single-Cell Sequencing of Immune Cells from Hemophilia a Patients with Inhibitors and Acquired Hemophilia a Patients

Enhao Li, Zekun Li, Jing Dai, Guoqing Liu, Jie Sun, Zhenping Chen, Runhui Wu, Xuefeng Wang, Wenman WU

Blood (2022) 140 (Supplement 1): 8428–8429.

https://doi.org/10.1182/blood-2022-169345

Published: 2022

Journal Articles

Baseline CRP and Ferritin Identify Patients at High Risk of Poor Outcomes after Axicabtagene Ciloleucel Despite Corticosteroid Prophylaxis

Blood (2022) 140 (Supplement 1): 4678–4680.

https://doi.org/10.1182/blood-2022-171084

Published: 2022

Journal Articles

The Experimental Gene Therapy on Type 2A/Iic VWD Mouse Model with AAV Vector Delivering Only VWF Propeptide Expression cassette4

Qian Liang, Ziqi Zhang, Xuefeng Wang, Wenman WU

Blood (2022) 140 (Supplement 1): 7782–7783.

https://doi.org/10.1182/blood-2022-169113

Published: 2022

Journal Articles

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Michael D. Jain, Bachisio Ziccheddu, Caroline A. Coughlin, Rawan Faramand, Anthony J. Griswold, Kayla M. Reid, Meghan Menges, Yonghong Zhang, Ling Cen, Xuefeng Wang, Mohammad Hussaini, Ola Landgren, Marco L. Davila, Jonathan H. Schatz, Frederick L. Locke, Francesco Maura

Blood (2022) 140 (5): 491–503.

https://doi.org/10.1182/blood.2021015008

Published: 2022

Includes: Supplemental data

Journal Articles

Structural basis of von Willebrand factor multimerization and tubular storage

Jianwei Zeng, Zimei Shu, Qian Liang, Jing Zhang, Wenman Wu, Xuefeng Wang, Aiwu Zhou

Blood (2022) 139 (22): 3314–3324.

https://doi.org/10.1182/blood.2021014729

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Blood (2021) 137 (19): 2621–2633.

https://doi.org/10.1182/blood.2020007445

Published: 2021

Includes: Supplemental data

Journal Articles

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Yanyan Shao, Wenman Wu, Guanqun Xu, Xuefeng Wang, Qiulan Ding

Blood (2019) 134 (20): 1745–1754.

https://doi.org/10.1182/blood.2018886069

Published: 2019

Includes: Supplemental data

Journal Articles

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

XI WU, M.S., Dai Jing, Fang Li, PhD, Qin Xu, PhD, Changming Chen, Qiulan Ding, Xuefeng Wang, MD, Wenman WU, MD

Blood (2019) 134 (Supplement_1): 442.

https://doi.org/10.1182/blood-2019-127694

Published: 2019

Journal Articles

Mutation of the CD28 Co-Stimulatory Domain Confers Enhanced CAR T Cell Function

Justin C. Boucher, PhD, Gongbo Li, PhD MBBS, Hiroshi Kotani, MD PhD, Maria Cabral, Dylan Morrissey, Sae Bom Lee, Kristen Spitler, Nolan Beatty, Bishwas Shrestha, PhD, Bin Yu, Aslamuzzaman Kazi, Xuefeng Wang, PhD, Said Sebti, PhD, Marco L. Davila, MD PhD

Blood (2019) 134 (Supplement_1): 248.

https://doi.org/10.1182/blood-2019-122954

Published: 2019

Journal Articles

The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy

Michael D. Jain, MD PhD, Rawan Faramand, MD, Verena Staedtke, MD PhD, Renyuan Bai, MBBS, Sae Bom Lee, Hiroshi Kotani, MD PhD, Kayla Reid, Kristen Spitler, Julio Chavez, Bijal Shah, MD, Christina A Bachmeier, PharmD, Marian Dam, ARNP, Brigett Brandjes, PA, Ricardo J Gonzalez, MD, John E Mullinax, MD PhD, Xuefeng Wang, PhD, Mohammad Hussaini, MD, Frederick L. Locke, MD, Marco L. Davila, MD PhD

Blood (2019) 134 (Supplement_1): 4105.

https://doi.org/10.1182/blood-2019-127305

Published: 2019

Journal Articles

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

Rawan Faramand, MD, Hiroshi Kotani, MD PhD, Dylan Morrissey, Bin Yu, Frederick L. Locke, MD, Michael D. Jain, MDPhD, Julio C. Chavez, MD, Xuefeng Wang, PhD, Asmita Mishra, MD, Christina A Bachmeier, PharmD, Renier J. Brentjens, MD PhD, Sarah Yoo, Jae H. Park, MD, Marco L. Davila, MD PhD

Blood (2018) 132 (Supplement 1): 95.

https://doi.org/10.1182/blood-2018-99-116539

Published: 2018

Journal Articles

Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

Blood (2018) 132 (Supplement 1): 2853.

https://doi.org/10.1182/blood-2018-99-118004

Published: 2018

Journal Articles

Effective Therapy for Murine Hemophilia A by Enhancing Factor VIII Expression in Platelets

Xuefeng Wang, PhD, Fu Richard, Carol H. Miao, PhD

Blood (2015) 126 (23): 5547.

https://doi.org/10.1182/blood.V126.23.5547.5547

Published: 2015

Journal Articles

Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays

Qiulan Ding, Likui Yang, Peyman Dinarvand, Xuefeng Wang, Alireza R. Rezaie

Blood (2015) 125 (15): 2428–2434.

https://doi.org/10.1182/blood-2014-12-617274

Published: 2015

Includes: Supplemental data

Journal Articles

Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells

Cathy X. Wang, Blythe D. Sather, Xuefeng Wang, Jennifer Adair, Iram Khan, Swati Singh, Shanshan Lang, Amie Adams, Gabrielle Curinga, Hans-Peter Kiem, Carol H. Miao, David J. Rawlings, Bruce E. Torbett

Blood (2014) 124 (6): 913–923.

https://doi.org/10.1182/blood-2013-12-546218

Published: 2014

Includes: Supplemental data

Journal Articles

Murine Hemophilia A With Or Without Pre-Existing Anti-Factor VIII Inhibitors Is Partially Corrected By Factor VIII Stored In Platelets After Intraosseous Infusion Of Lentiviral Vectors Into Bone Marrow Without Preconditioning

Xuefeng Wang, PhD, Simon C. Shin, Chiang Andy, Dao Pan, PhD, David Rawlings, MD, Carol H. Miao, PhD

Blood (2013) 122 (21): 719.

https://doi.org/10.1182/blood.V122.21.719.719

Published: 2013

NARROW

CAR-T Phenotype and Efficacy Is Impaired By Lymphoma-Associated CD39 + T Cells

Thrombosis Caused By a Novel Coagulation Factor IX Mutation (FIX Shanghai II)

Sexual Health in Young Adult Patients after Chimeric Antigen Receptor T-Cell Therapy

Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup

Single-Cell Sequencing of Immune Cells from Hemophilia a Patients with Inhibitors and Acquired Hemophilia a Patients

Baseline CRP and Ferritin Identify Patients at High Risk of Poor Outcomes after Axicabtagene Ciloleucel Despite Corticosteroid Prophylaxis

The Experimental Gene Therapy on Type 2A/Iic VWD Mouse Model with AAV Vector Delivering Only VWF Propeptide Expression cassette4

Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma

Structural basis of von Willebrand factor multimerization and tubular storage

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

Mutation of the CD28 Co-Stimulatory Domain Confers Enhanced CAR T Cell Function

The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

Effective Therapy for Murine Hemophilia A by Enhancing Factor VIII Expression in Platelets

Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays

Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells

Murine Hemophilia A With Or Without Pre-Existing Anti-Factor VIII Inhibitors Is Partially Corrected By Factor VIII Stored In Platelets After Intraosseous Infusion Of Lentiviral Vectors Into Bone Marrow Without Preconditioning

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only